MindBio Therapeutics Expands AI Voice Diagnostics Platform with Fatigue Detection Technology

MindBio Therapeutics announced the development of AI-powered fatigue recognition technology for its Edge AI Intoxication Detection Kiosks, targeting high-risk industries like aviation, road transport, and mining, with initial commercial testing expected in late Q2 2026.

SA Metrowire Staff
Technology
MindBio Therapeutics Expands AI Voice Diagnostics Platform with Fatigue Detection Technology

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) has announced the development of AI-powered fatigue recognition technology that analyzes voice patterns, intended to be added as a commercial feature to the company’s Edge AI Intoxication Detection Kiosks. Designed for high-risk industries including aviation, road transport and mining, the fatigue detection module complements MindBio’s broader voice-based diagnostics platform aimed at identifying intoxication and neurological impairment. Initial commercial testing of the kiosk platform is expected in late second quarter 2026.

The fatigue detection technology leverages the same underlying voice analysis capabilities that MindBio has developed for alcohol and drug intoxication detection. The company’s AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. By expanding into fatigue detection, MindBio is addressing a critical safety need in industries where operator alertness is paramount. Fatigue is a leading cause of accidents in transportation, mining, and construction, and current detection methods often rely on subjective self-reporting or expensive wearable devices. Voice-based analysis offers a non-invasive, scalable alternative that can be deployed at entry points or check-in stations.

MindBio is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement. The addition of fatigue detection represents a natural extension of this platform, potentially increasing its utility and commercial appeal. The company expects that the combined intoxication and fatigue detection capabilities will provide a comprehensive safety solution for high-risk workplaces.

The announcement comes as MindBio prepares for initial commercial testing of its kiosk platform later in 2026. The company’s focus on voice-based diagnostics positions it at the intersection of artificial intelligence and occupational health, a market with growing demand as industries seek to improve safety and reduce liability. The technology could also find applications in other sectors such as healthcare, where monitoring patient alertness or cognitive impairment is important.

MindBio’s development of fatigue detection technology highlights the potential of voice analysis as a tool for real-time health and safety monitoring. As the company moves toward commercialization, it will likely need to demonstrate the accuracy and reliability of its system in real-world conditions. The success of the platform could set a new standard for non-invasive impairment detection in safety-critical industries.

Blockchain Registration

QR Code for Blockchain Registration